academic article

• DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. 2017
• A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection..  Journal of hepatology.  61:1238-1246. 2014